$DAVA

Endava plc (NYSE: DAVA) Scrutinized Amid Board Placing CFO On Leave, 25% Stock Drop -- HBSS

Endava plc (NYSE: DAVA) shares fell over 25% on September 22, 2026, after the company placed its CFO on leave and announced an internal accounting investigation. The board's decision followed concerns raised by external auditors. The company also delayed its quarterly and annual reports. Hagens Berman is investigating potential securities law violations and urging affected investors to come forward.

Original reporting
Published Sep 25, 2026, 4:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 4:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Endava plc (NYSE: DAVA) Scrutinized Amid Board Placing CFO On Leave, 25% Stock Drop -- HBSS — source image
Decision brief

The 30-second read

$DAVABearishMed
01

Why it matters

The news suggests heightened risk of restatements, possible SEC enforcement, and short‑term volatility.

02

Market read

The announcement is a primary disclosure of a governance crisis that materially moved the stock, creating a short‑term trading opportunity.

03

What to watch

Potential short‑term buying pressure from distressed‑value funds seeking a turnaround play.

Relevance 7/10Novelty 8/10Timing: post‑market Sep 22, 2026

Background

Endava announced CFO leave and an internal probe after auditors raised concerns about accounting of certain contracts, leading to a delayed filing and a >25% share price decline.

Company-level read

Ticker impact

$DAVABearishHigh confidence
Context

Endava placed its CFO on administrative leave and disclosed an internal accounting investigation, causing a >25% share price drop.

Expected impact

Further downside pressure expected as investigation proceeds.

Evidence & confidence

The announcement triggered a large intraday move and raises risk of restatements or regulatory action.

Market effects

Raises scrutiny on other mid‑cap software services firms regarding accounting controls.

Potential ripple in European tech listings with similar governance structures.

Highlights heightened regulator and investor focus on corporate governance worldwide.

Counterpoint

If the investigation finds no material misstatements, the stock could rebound sharply from oversold levels.

Key entities

  • Endava plc

    Mid‑cap software services provider listed on NYSE (DAVA).

  • Hagens Berman

    Shareholder rights firm leading the investigation.

Related articles

$DAVAMed

Here is Why Endava (DAVA) is One of the Underperforming Tech Stocks to Buy According to Analysts

Endava (NYSE:DAVA) reported FQ3 2026 revenue of £178.5 million, down 8.4% year over year, citing uneven demand and longer deal cycles. The company recorded a £364.6 million goodwill impairment and related tax charges, resulting in a diluted loss per share of £7.55. For FQ4, it expects revenue of £181.0–£185.0 million and adjusted diluted EPS of £0.09–£0.13.

$QCOMMed

Qualcomm Renews Apple Patent Deal: Can QTL Regain Momentum?

Qualcomm (QCOM) renewed its global patent license agreement with Apple, effective April 1, 2027. QTL revenues fell 3% YoY to $1.28B in Q3 2026. QCT's share in upcoming iPhone launch expected to be below 20%. QTL revenues projected at $1.2B-$1.4B for Q4 2026, with EBT margin of 68-72%. Recovery depends on expanding into new markets. QCOM shares up 14.5% YoY, trading at 19.37x forward earnings.